表紙
市場調査レポート

臨床ラボサービス市場:成長機会・競合分析・主要企業のプロファイル

Clinical Lab Services Market (Growth Opportunities, Competitive Analysis and Competitor Profiles)

発行 Kalorama Information 商品コード 239695
出版日 ページ情報 英文 200 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
臨床ラボサービス市場:成長機会・競合分析・主要企業のプロファイル Clinical Lab Services Market (Growth Opportunities, Competitive Analysis and Competitor Profiles)
出版日: 2013年12月20日 ページ情報: 英文 200 Pages
概要

医師による診断の約80%はラボ検査の結果に基づくと推計されており、これらの検査の多くは臨床ラボサービスプロバイダーに委託されています。

当レポートでは、世界および米国の臨床ラボサービス市場について調査分析し、臨床ラボ事業者により実施される各種検査の種類と概要、ラボタイプ別の主要統計データ、ラボ市場の成長に影響を及ぼす疾患発症率・その他の動向、地域/国・ラボタイプ・検査タイプ別の市場分析(一部予測)、米国における主要企業の市場シェア、主要な臨床ラボプロバイダーのプロファイルなどをまとめ、概略下記の構成でお届けいたします。

第1章 エグゼクティブサマリー

第2章 産業概要

  • 臨床ラボの概要
  • 検査・サービス
    • ルーチン検査
      • 血球計算
      • コレステロール値検査
      • HIV検査
      • Pap試験
      • 妊娠検査
      • 薬物乱用検査
      • 尿検査
    • 特殊検査
      • 内分泌系
      • 特殊検査
      • 遺伝
      • 免疫・分子細菌
      • 血清
      • 毒性検査
    • 産業構造
    • 病院ベースのラボ
    • フィジシャンオフィスのラボ
    • 独立系臨床ラボ
    • CLIAラボ登録・タイプ別ラボ
    • 疾患発症率
    • 人口動態
    • 寿命
    • 規制概要
    • CLIA(臨床検査改善促進法)の適応免除
    • 保険と償還
    • ラボサービスの支払い者タイプ
    • Medicareによる償還の動向
    • 商用保険プロバイダー
    • 医療改革の課題
    • 情報技術の新しい開発
    • 国際市場と動向
    • アジア太平洋
    • 欧州
    • ラテンアメリカ
    • 中東、など

第3章 主要企業

  • サマリー
  • Bio-Reference Laboratories
  • Clarient, Inc.
  • DaVita Healthcare Partners, Inc.
  • Genomic Health, Inc.
  • Genoptix, Inc.
  • Laboratory Corporation of America
  • Myriad Genetics, Inc.
  • Quest Diagnostics, Inc.
  • Spectra Laboratories
    • 企業概要
    • パフォーマンスレビュー
    • 主な買収・提携
    • 製品・サービス
    • 成長戦略
    • 所在地、など

第4章 市場動向・市場のサマリー

  • 市場概要
  • 市場分析:ラボタイプ別
  • 市場分析:テストタイプ別
  • 競合分析
  • 国際市場の概要

付録:主要企業・組織のリスト

付録:州のCLIAオフィス

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: KLI5167692

The market for clinical lab services is dynamic. It is estimated that approximately 80% of physician's diagnoses are a result of laboratory tests, and a fair number of these tests are sent to clinical lab service providers. There is constant pressure to reduce healthcare spending, and that in turn is shifting healthcare utilization in favor of the laboratory. This has not escaped the attention of major competitors who operate in the industry, and those planning to enter. Clinical Laboratory Services (Markets, Growth Opportunities, Competitive Analysis and Competitor Profiles), provides an in-depth market overview, a total market analysis, analysis by laboratory type, and by routine and specialty testing and a review of the latest trends driving growth. Revenues and forecasts, segment breakouts and market share presented are for the U.S. market, but international clinical lab service markets are estimated and forecasted in this report.

Key market data provided includes:

  • Hospital, Physician and Independent Lab Statistics
  • Major Tests Performed by Clinical Lab Companies
  • Disease Incidence and Trends Driving Lab Business
  • Market Forecast to 2018
  • Geographic Breakout of Clinical Lab Services Market (includes US, Europe Asia with specific breakouts for Germany, Japan, China, India and Brazil)
  • Market Breakdown by Lab Type (Hospital, Physician, Independent)
  • Market Breakdown by Test Type (Specialty, Routine)
  • US Market Share of Competitors
  • Competitive Analysis of Leading clinical Lab Providers

A trend towards preventive and risk factor testing has been noted in several disciplines, particularly in the areas of oncology, endocrinology, and gynecology. Physicians in these areas are taking full advantage of testing for early detection and disease prevention.

Some of the other issues and trends explored in this study include:

  • U.S. Demographics
  • Types of Specialty Tests
  • Growing Competition
  • Increasing Life Expectancy
  • Growing Incidence of Disease
  • New Product Offerings
  • Regulatory Environment
  • Insurance and Reimbursement
  • Payer Types
  • Developments in Personalized Medicine

A competitive analysis of leading clinical laboratory providers includes:

  • Quest Diagnostics, Inc.
  • Laboratory Corporation of America (LabCorp)
  • Genomic Health
  • Genoptix, Inc.
  • Genzyme Corporation
  • DaVita
  • Clarient, Inc.
  • Spectra Laboratories
  • Bio-Reference Laboratories

The information in this report is the result of interviews with executives and market experts, as well as thorough research of secondary sources such as company literature, trade publications and medical and business journals. The emphasis Kalorama puts on primary research guarantees that new insights will be uncovered that are not available from any other source. The most important part of Kalorama's efforts is its superior analysis of company activities and their true significance in the marketplace.

Historical data was provided for the years 2008- 2012, with forecast data provided for 2013 through 2017. A competitive analysis is provided for the year 2013. The forecasted market analysis for 2013-2017 was largely based on demographic trends, new developments, company performance trends, mergers and acquisitions, and national expansion.

Table of Contents

EXECUTIVE SUMMARY

  • Industry at a Glance
  • Scope and Methodology
  • World Market Summary
  • The U.S. Clinical Laboratory Market
  • Key Issues and Trends Affecting the Market
  • Leading Market Participants

INDUSTRY OVERVIEW

  • Clinical Laboratory Description
  • Testing and Services
  • Routine Testing
  • Blood Cell Count
  • Cholesterol Level Testing
  • HIV Testing
  • Pap Testing
  • Pregnancy Testing
  • Substance Abuse Testing
  • Urinalysis
  • Specialty Testing
  • Endocrinology
  • Esoteric Testing
  • Genetics
  • Immunology and Molecular Microbiology
  • Oncology
  • Serology
  • Toxicology
  • Industry Structure
  • Hospital-based Laboratories
  • U.S. Hospital Data
  • U.S. Hospital Stay Stats
  • International Hospital/Acute Care Data
  • International Hospital Stay Stats
  • Physician-office Laboratories
  • Number of U.S. Physicians
  • Independent Clinical Laboratories

CLIA Laboratory Registration, Laboratories by Type

ISSUES AND TRENDS IN THE CLINICAL LABORATORY INDUSTRY

  • Issues and Trends Overview
  • Demographics
  • Global Demographics
  • Global Population Over Age 65
  • U.S. Demographics
  • U.S. Population Over Age 65
  • Life Expectancy
  • Incidence of Diseases
  • Surgical Procedure Volumes
  • Regulatory Overview
  • Certificate of Waiver
  • Certificate of Provider-Performed Microscopy Procedures (PPMP)
  • Certificate of Compliance and Certificate of Accreditation
  • States Exempt from Federal Clinical Laboratory Improvements Amendments (CLIA) of 1988
  • Insurance and Reimbursement
  • Laboratory Service Payer Types
  • Trends in Medicare Reimbursement
  • Health Care Reform
  • Bundled Insurance Payments for ESRD Patients
  • HIPPA
  • Commercial Insurance Providers
  • New Developments in Information Technology

LEADING MARKET PARTICIPANTS

  • Summary
  • Bio-Reference Laboratories
  • Company Overview
  • Performance Review
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
  • Growth Strategy
  • Locations
  • Clarient, Inc. (A GE Healthcare Company)
  • Company Overview
  • Performance Review
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
  • Locations
  • DaVita Healthcare Partners, Inc.
  • Company Overview
  • Performance Review
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
  • Growth Strategy
  • Locations
  • Genomic Health, Inc.
  • Company Overview
  • Performance Review
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
  • Growth Strategy
  • Locations
  • Genoptix, Inc.
  • Company Overview
  • Performance Review
  • Products and Services
  • Growth Strategy
  • Locations
  • Laboratory Corporation of America
  • Company Overview
  • Performance Review
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
  • Growth Strategy
  • Locations
  • Myriad Genetics, Inc.
  • Company Overview
  • Performance Review
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
  • Growth Strategy
  • Locations
  • Quest Diagnostics, Inc.
  • Company Overview
  • Performance Review
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
  • Growth Strategy
  • Business Locations
  • Spectra Laboratories
  • Company Overview
  • Performance Review
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
  • Growth Strategy
  • Locations

MARKET TRENDS AND SUMMARY

  • World Market Overview
  • U.S. Market Overview
  • Market Analysis by Laboratory Type
  • Hospital-based Clinical Laboratory Segment
  • Independent Laboratory Segment
  • Physician-Office Laboratory Segment
  • Market Analysis by Test Type
  • Routine Testing
  • Specialty Testing
  • U.S. Competitive Analysis
  • International Market Overview
  • International Markets and Trends
  • Asia Pacific
  • Europe and Middle East
  • Latin America

LIST OF MAJOR COMPANIES AND ORGANIZATIONS

STATE CLIA OFFICES

LIST OF EXHIBITS

EXECUTIVE SUMMARY

  • Table 1-1: World Clinical Laboratory Market Analysis, 2008-2018
  • Figure 1-1: World Clinical Laboratory Market Analysis: 2008-2018
  • Table 1-2: U.S. Clinical Laboratory Market Analysis, 2008-2018
  • Figure 1-2: U.S. Clinical Laboratory Market Analysis: 2008-2018
  • Figure 1-3: Leading Market Participant Revenues, 2012* ($millions)

INDUSTRY OVERVIEW

  • Table 2-1: Laboratory Reference Parameters for CBC
  • Table 2-2: High Cholesterol Risk Categories
  • Table 2-3: HCG Levels in Pregnant Women by Days Past Ovulation
  • Table 2-4: Substance Detection Periods by Test Method
  • Table 2-5: Normal Reference Levels in a Medical Urinalysis
  • Figure 2-1: Growth in Clinical Laboratories, 1997-2013
  • Table 2-6: U.S. Registered Hospitals by Type, 2008 through 2011
  • Figure 2-2: Distribution of U.S. Registered Hospitals by Type, 2011
  • Figure 2-3: Number of Hospitals in the U.S., 1975-2005, Estimated 2015
  • Table 2-7: Statistics for U.S. Hospitals, 2011
  • Table 2-8: Leading For-Profit U.S. Hospital Chains, 2010 and 2012
  • Table 2-9: U.S. Hospital Length of Stay, Average by Age Group
  • Figure 2-4: U.S. Hospital Length of Stay, Average by Age Group
  • Table 2-10: Registered Hospitals and Acute Care Centers by Country
  • Figure 2-5: Registered Hospitals and Acute Care Centers by Country
  • Table 2-11: Average International Length of Stay for Acute Care Centers, by Country 2011
  • Figure 2-6: Average International Length of Stay, by Country 2011
  • Table 2-12: Physicians in the U.S. by Specialty, 1970-2010
  • Figure 2-7: Number of Physician Offices, United States, 2000-2009
  • Table 2-13: Medical Doctors per 1,000 Population by Country, 2011
  • Figure 2-8: Medical Doctors per 1,000 Population by Country, 2011
  • Table 2-14: Leading U.S. Independent Laboratory Groups, mid-2013
  • Figure 2-9: Leading U.S. Independent Laboratory Groups, Distribution of Centers, mid-2013
  • Figure 2-10: U.S. CLIA Clinical Laboratory Registration by Primary Laboratory Type: 6/2013
  • Table 2-15: CLIA Registered Laboratories by Type of Facility (Exempt/Non-Exempt Combined) June 2013
  • Figure 2-11: Change in CLIA Registered Laboratories by Type of Facility (Exempt/Non-Exempt Combined) June 2011 versus June 2013

ISSUES AND TRENDS IN THE CLINICAL LABORATORY INDUSTRY

  • Table 3-1: The Global Population, 1980-2050
  • Figure 3-1: The Global Population, 1980-2050
  • Table 3-2: Global Population Trends Age 65+, 2000-2050
  • Figure 3-2: Global Population Trends Age 65+, 2000-2050
  • Table 3-3: The U.S. Population, 1980-2050
  • Figure 3-3: The U.S. Population, 1980-2050
  • Table 3-4: Percent U.S. Population Over Age 65 by Year, 2000-2050
  • Figure 3-4: United States Population Trend Age 65+, 2000-2050
  • Table 3-5: Average Life Expectancy in Years by Country 1980 and 2012
  • Figure 3-5: Average Life Expectancy in Years by Country 1980 and 2012
  • Table 3-6: U.S. Prevalence of Selected Medical Conditions
  • Figure 3-6: U.S. Prevalence of Selected Medical Conditions
  • Table 3-7: Surgical Procedures in the United States, by Procedure Category, 2010
  • Table 3-8: Selected CLIA Waived Laboratory Tests
  • Table 3-9: Provider-Performed Microscopy Procedures
  • Figure 3-7: Clinical Laboratory Certificate of Accreditation Issued by Organization (non-exempt laboratories only), June 2013
  • Table 3-10: Clinical Laboratory Certificates Issued by Type (non-exempt laboratories only), June 2013
  • Figure 3-8: Clinical Laboratory Certificates Issued by Selected State (non-exempt laboratories only), June 2013
  • Figure 3-9: Clinical Laboratory Certificates Issued by Type (non-exempt laboratories only), June 2013
  • Table 3-11: CLIA Exempt States, Number of Laboratories, June 2013
  • Table 3-12: Health Insurance Trends in the United States, Estimated 2010* (millions)
  • Figure 3-10: Health Insurance Coverage in the United States by Type, Estimated 2010*
  • Table 3-13: U.S. Clinical Laboratory Clients and Payers by Type, 2013 (%)
  • Figure 3-11: Clinical Laboratory Clients and Payers by Type
  • Table 3-14: Medicare Reimbursement Trends, 2009 vs. 2013
  • Table 3-14 (continued): Medicare Reimbursement Trends, 2009 vs. 2013
  • Table 3-15: ESRD-Related Laboratory Tests Included in New Bundle Payment Structure
  • Table 3-16: Comparison Between New Bundled and Composite Medicare Reimbursement Program (1983-2010 and 2011+)
  • Table 3-17: Leading Commercial Insurance Providers, 2012
  • Table 3-18: Leading Laboratory Information Management System Providers
  • Table 3-19: Release of Laboratory Test Results Directly to Patients, by State
  • Table 3-19 (continued): Release of Laboratory Test Results Directly to Patients, by State

LEADING MARKET PARTICIPANTS

  • Figure 4-1: Leading Market Participant Revenues, 2012* ($millions)
  • Table 4-1: Corporate Details of Bio-Reference Laboratories
  • Figure 4-2: Bio-Reference's Sales to Third Parties, 2008-2012 ($millions)
  • Table 4-2: Company Details for Clarient
  • Figure 4-3: Clarient's Sales to Third Parties, 2008 and 2009 and Estimated 2010, 2011, and 2012 ($millions)
  • Table 4-3: Corporate Details of DaVita
  • Figure 4-4: DaVita's Revenues, 2008-2012 ($millions)
  • Table 4-4: Corporate Details of Genomic Health
  • Figure 4-5: Genomic Health's Sales to Third Parties, 2008-2012 ($millions)
  • Table 4-5: Company Details for Genoptix
  • Figure 4-6: Novartis' Sales to Third Parties, 2008-2012 ($millions)
  • Table 4-6: Corporate Details of Laboratory Corporation of America
  • Figure 4-7: Laboratory Corporation of America's Sales to Third Parties, 2008-2012 ($millions)
  • Table 4-7: Corporate Details for Myriad Genetics
  • Figure 4-8: Myriad Genetics' Sales to Third Parties, 2008-2012 ($millions)
  • Table 4-8: Corporate Details of Quest Diagnostics
  • Figure 4-9: Quest Diagnostics' Clinical Testing Sales to Third Parties, 2008-2012 ($millions)
  • Table 4-9: Company Details for Spectra Laboratories
  • Figure 4-10: Fresenius Medical Care Revenues and Estimated Spectra Clinical Testing Sales to Third Parties, 2008-2012 ($millions)

MARKET TRENDS AND SUMMARY

  • Table 5-1: World Clinical Laboratory Market Analysis, 2008-2018
  • Figure 5-1: World Clinical Laboratory Market Analysis: 2008-2018
  • Table 5-2: U.S. Clinical Laboratory Market Analysis, 2008-2018
  • Figure 5-2: U.S. Clinical Laboratory Market Analysis: 2008-2018
  • Table 5-3: U.S. Clinical Laboratory Market Analysis by Laboratory Type, 2008-2018
  • Figure 5-3: U.S. Clinical Laboratory Market Analysis by Laboratory Type, 2008-2018
  • Figure 5-4: U.S. Clinical Laboratory Market Share by Laboratory Type, 2013
  • Figure 5-5: U.S. Clinical Laboratory Market Share by Laboratory Type, 2018
  • Figure 5-6: U.S. Clinical Laboratory Market Share by Test Type, 2013
  • Table 5-4: U.S. Clinical Laboratory Market Analysis by Test Type, 2008-2018
  • Figure 5-7: U.S. Clinical Laboratory Market Analysis by Test Type, 2008-2018
  • Figure 5-8: U.S. Clinical Laboratory Market Analysis: Routine Testing Market Trend, 2008-2018149
  • Figure 5-9: U.S. Clinical Laboratory Market Analysis: Specialty Testing by Type, 2013
  • Figure 5-10: U.S. Clinical Laboratory Market Analysis: Specialty Testing Market Trend, 2008-2018152
  • Table 5-5: Estimated U.S. Laboratory Service Revenues and Market Share of Leading Clinical Laboratory Providers 2013
  • Figure 5-11: Estimated U.S. Laboratory Service Revenues and Market Share of Leading Clinical Laboratory Providers 2013
  • Figure 5-12: Estimated U.S. Laboratory Service Revenues for Leading Clinical Laboratory Providers 2010 vs. 2013
  • Table 5-6: Global Clinical Laboratory Market Analysis, Revenues by Region, 2013
  • Figure 5-13: Global Clinical Laboratory Market Analysis, Revenues by Region, 2013

LIST OF MAJOR COMPANIES AND ORGANIZATIONS

STATE CLIA OFFICES

Back to Top